Parkinson’s disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Wilson E, Umans J, Swarovski M, Minhas P, Mendiola J, Midttun Ø, Ulvik A, Shahid-Besanti M, Linortner P, Mhatre S, Wang Q, Channappa D, Corso N, Tian L, Fredericks C, Kerchner G, Plowey E, Cholerton B, Ueland P, Zabetian C, Gray N, Quinn J, Montine T, Sha S, Longo F, Wolk D, Chen-Plotkin A, Henderson V, Wyss-Coray T, Wagner A, Mormino E, Aghaeepour N, Poston K, Andreasson K. Parkinson’s disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction. Npj Parkinson's Disease 2025, 11: 96. PMID: 40287426, PMCID: PMC12033312, DOI: 10.1038/s41531-025-00964-7.Peer-Reviewed Original ResearchCerebral spinal fluidKynurenine pathwayKynurenic acidQuinolinic acidSites of brainB-vitamin statusParkinson's diseasePD clinical featuresVitamin B6 deficiencyKP metabolitesClinical featuresClinical manifestationsCerebral inflammationClinical symptomsPatient subgroupsB6 deficiencySpinal fluidPathway dysfunctionKynurenineCompare bloodDiseaseInflammationVitaminIncreased QASoluble TREM2
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply